Search research articles
Contact Us
Filters
Showing results (471-480 of 509) with videos related to
Page
of 51
Sort By:
Cell & Bioscience
|
May 7, 2022
TRPM8 deficiency attenuates liver fibrosis through S100A9-HNF4α signaling
Qiang Liu, Xiaohua Lei, Zhenyu Cao, et al.
Zhonghua Xin Xue Guan Bing Za Zhi
|
April 3, 2020
[Value of absolute quantification of myocardial perfusion by PET in detecting coronary microvascular disease in patients with non-obstructive coronaries]
P Wu, X S Guo, X Zhang, et al.
Disease Markers
|
August 1, 2022
Transient Receptor Potential Vanilloid-1 (TRPV1) Alleviates Hepatic Fibrosis via TGF-<i>β</i> Signaling
Ke Qian, Xiaohua Lei, Guoxing Liu, et al.
Current Oncology (Toronto, Ont.)
|
December 31, 2020
Longitudinal health utilities, symptoms and toxicities in patients with <i>ALK-</i>rearranged lung cancer treated with tyrosine kinase inhibitors: a prospective real-world assessment
B C Tse, B I Said, Z J Fan, et al.
Cell Death & Disease
|
December 16, 2022
TRPM8 contributes to liver regeneration via mitochondrial energy metabolism mediated by PGC1α
Xiaohua Lei, Qiang Liu, Wei Qin, et al.
Cell Death & Disease
|
March 21, 2023
Correction: TRPM8 contributes to liver regeneration via mitochondrial energy metabolism mediated by PGC1α
Xiaohua Lei, Qiang Liu, Wei Qin, et al.
Immunology Letters
|
April 18, 2001
CCR1-specific non-peptide antagonist: efficacy in a rabbit allograft rejection model
R Horuk, S Shurey, H P Ng, et al.
Arthritis and Rheumatism
|
March 1, 1996
The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus
D Gladman, E Ginzler, C Goldsmith, et al.
British Journal of Pharmacology
|
August 24, 2012
Protein engineering and preclinical development of a GM-CSF receptor antibody for the treatment of rheumatoid arthritis
R R Minter, E S Cohen, B Wang, et al.
Cancer Chemotherapy and Pharmacology
|
October 11, 2001
A phase I and pharmacologic study of 9-aminocamptothecin administered as a 120-h infusion weekly to adult cancer patients
R R Thomas, W Dahut, N Harold, et al.
Page
of 51
Search research articles
Search
Showing results (471-480 of 509) with videos related to
Sort By:
Page
of 51
Cell & Bioscience
|
May 7, 2022
TRPM8 deficiency attenuates liver fibrosis through S100A9-HNF4α signaling
Qiang Liu, Xiaohua Lei, Zhenyu Cao, et al.
Zhonghua Xin Xue Guan Bing Za Zhi
|
April 3, 2020
[Value of absolute quantification of myocardial perfusion by PET in detecting coronary microvascular disease in patients with non-obstructive coronaries]
P Wu, X S Guo, X Zhang, et al.
Disease Markers
|
August 1, 2022
Transient Receptor Potential Vanilloid-1 (TRPV1) Alleviates Hepatic Fibrosis via TGF-<i>β</i> Signaling
Ke Qian, Xiaohua Lei, Guoxing Liu, et al.
Current Oncology (Toronto, Ont.)
|
December 31, 2020
Longitudinal health utilities, symptoms and toxicities in patients with <i>ALK-</i>rearranged lung cancer treated with tyrosine kinase inhibitors: a prospective real-world assessment
B C Tse, B I Said, Z J Fan, et al.
Cell Death & Disease
|
December 16, 2022
TRPM8 contributes to liver regeneration via mitochondrial energy metabolism mediated by PGC1α
Xiaohua Lei, Qiang Liu, Wei Qin, et al.
Cell Death & Disease
|
March 21, 2023
Correction: TRPM8 contributes to liver regeneration via mitochondrial energy metabolism mediated by PGC1α
Xiaohua Lei, Qiang Liu, Wei Qin, et al.
Immunology Letters
|
April 18, 2001
CCR1-specific non-peptide antagonist: efficacy in a rabbit allograft rejection model
R Horuk, S Shurey, H P Ng, et al.
Arthritis and Rheumatism
|
March 1, 1996
The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus
D Gladman, E Ginzler, C Goldsmith, et al.
British Journal of Pharmacology
|
August 24, 2012
Protein engineering and preclinical development of a GM-CSF receptor antibody for the treatment of rheumatoid arthritis
R R Minter, E S Cohen, B Wang, et al.
Cancer Chemotherapy and Pharmacology
|
October 11, 2001
A phase I and pharmacologic study of 9-aminocamptothecin administered as a 120-h infusion weekly to adult cancer patients
R R Thomas, W Dahut, N Harold, et al.
Page
of 51